These effects are continuous, so the individual can rely on a steady influence from the medication between doses
First, there is supporting evidence for the safety of GLP-1RAs across the board of cognitive and mental disorders, as we retrieved very few studies 44,159,181,182,193,205 suggesting worse neuropsychiatric outcomes associated with these medications (Tables 16, Fig
Heres how we can help: Personalized Plans : We create custom treatment plans based on your health profile and fitness goals
doi: 10.3389/fphar.2024.1414268 Received 08 April 2024 Accepted 13 May 2024 Published 03 June 2024 Volume 15 - 2024 Edited by Sheyu Li, Sichuan University, China Reviewed by Yiyuan Gao, Sichuan University, China Heyue Du, TidalHealth Neurosurgery, United States Erin St